Investing news
Latest investment headlines, research & analysis

Will Pfizer approach Viking Therapeutics with a buyout proposal?
- Pfizer discontinues development of weight-loss pill due to a serious adverse effect.
- Investors now expect it to acquire VKTX to expand in the anti-obesity market.
- There are several reasons, however, why PFE may not go after Viking Therapeutics.
Investors are running into Viking Therapeutics (NASDAQ: VKTX) this week after an incident of drug-induced liver injury pushed Pfizer (NYSE: PFE) into terminating the development of its weight-loss pill. Viking’s share price has gained % in recent sessions on speculation that PFE will now resort to an acquisition to expand its footprint in the weight-loss […]
April 15, 2025
Trending news
Trading ideas & analysis

AppLovin stock price forecast: buy the dip or sell the rip?
April 15, 2025